MPLT compared with AVLN: revenue, margins and what each company keeps, and the suppliers and customers both name

MPLTMapLight Therapeutics, Inc.

Mkt capRevenueRevenue

AVLNAvalyn Pharma Inc.

Mkt capRevenueRevenue

Compare

MPLTMapLight Therapeutics, Inc.

AVLNAvalyn Pharma Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

MPLT

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.4%▲+1.47%×0.09

May 15 '26—▼−1.91%—

Q1 FY26—▲+6.01%—

Jan 9 '26—▲+4.83%—

AVLN1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+5.41%—

= impliedMPLT realized, solidAVLN realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

MPLTMapLight Therapeutics, Inc.

6.87▲+10.49%· post 7.57

Mkt cap$314.8M

AVLNAvalyn Pharma Inc.

28.84▲+8.14%· post 28.81

ClosedNov 6 '26

Mkt cap$864.3M

Compare

ClosedNov 6 '26

MPLTMapLight Therapeutics, Inc.

AVLNAvalyn Pharma Inc.

6.87▲+10.49%post 7.57

Price

28.84▲+8.14%post 28.81

$314.8M

Mkt cap

$864.3M

MPLT6.87▲+10.49%vsAVLN28.84▲+8.14%ClosedNov 6 '26